With Big Pharma Failing, Ackman And Novartis AG (NVS) Try A New Blueprint For Drug Companies
4/23/2014 8:11:34 AM
Yesterday in a move that returned attention to healthcare takeovers, Bill Ackman, CEO of the hedge fund Pershing Square Capital, announced a bold and unusual move by partnering with pharmaceutical company, Valeant Pharmaceuticals International VRX -0.89%, Inc. to acquire a major stake in another biotech. In this case it is Allergan AGN +0.58%, Inc., the makers of the injectable wrinkle-remover BOTOX, and several ophthalmic treatments.
Hey, check out all the research scientist jobs. Post your resume today!
comments powered by